A detailed history of Newfound Research LLC transactions in Embecta Corp. stock. As of the latest transaction made, Newfound Research LLC holds 97 shares of EMBC stock, worth $1,940. This represents 0.01% of its overall portfolio holdings.

Number of Shares
97
Previous 97 -0.0%
Holding current value
$1,940
Previous $2,000 50.0%
% of portfolio
0.01%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

BUY
$24.78 - $33.36 $2,403 - $3,235
97 New
97 $2,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.16B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Newfound Research LLC Portfolio

Follow Newfound Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newfound Research LLC with notifications on news.